Abeona Therapeutics Stock Price Prediction
| ABEO Stock | USD 6.03 0.09 1.52% |
Oversold Vs Overbought
44
Oversold | Overbought |
EPS Estimate Next Quarter (0.41) | EPS Estimate Current Year (1.56) | EPS Estimate Next Year (1.12) | Wall Street Target Price 16.75 | Quarterly Revenue Growth (1.00) |
Using Abeona Therapeutics hype-based prediction, you can estimate the value of Abeona Therapeutics from the perspective of Abeona Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Abeona Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Abeona because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Abeona Therapeutics after-hype prediction price | USD 6.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Abeona |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abeona Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abeona Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Abeona Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Abeona Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Abeona Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Abeona Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Abeona Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Abeona Therapeutics' historical news coverage. Abeona Therapeutics' after-hype downside and upside margins for the prediction period are 3.49 and 8.57, respectively. We have considered Abeona Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Abeona Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Abeona Therapeutics is based on 3 months time horizon.
Abeona Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Abeona Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abeona Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Abeona Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.54 | 0.00 | 0.01 | 8 Events / Month | 16 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
6.03 | 6.03 | 0.00 |
|
Abeona Therapeutics Hype Timeline
Abeona Therapeutics is presently traded for 6.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Abeona is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.16%. %. The volatility of related hype on Abeona Therapeutics is about 7352.63%, with the expected price after the next announcement by competition of 6.04. About 78.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.05. Abeona Therapeutics had not issued any dividends in recent years. The entity had 1:25 split on the 5th of July 2022. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Abeona Therapeutics Basic Forecasting Models to cross-verify your projections.Abeona Therapeutics Related Hype Analysis
Having access to credible news sources related to Abeona Therapeutics' direct competition is more important than ever and may enhance your ability to predict Abeona Therapeutics' future price movements. Getting to know how Abeona Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Abeona Therapeutics may potentially react to the hype associated with one of its peers.
Abeona Therapeutics Additional Predictive Modules
Most predictive techniques to examine Abeona price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Abeona using various technical indicators. When you analyze Abeona charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Abeona Therapeutics Predictive Indicators
The successful prediction of Abeona Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Abeona Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Abeona Therapeutics based on analysis of Abeona Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Abeona Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Abeona Therapeutics's related companies. | 2023 | 2024 (projected) | Dividend Yield | 1.6K | 1.6K | Price To Sales Ratio | 30.6 | 29.07 |
Story Coverage note for Abeona Therapeutics
The number of cover stories for Abeona Therapeutics depends on current market conditions and Abeona Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Abeona Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Abeona Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Abeona Therapeutics Short Properties
Abeona Therapeutics' future price predictability will typically decrease when Abeona Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Abeona Therapeutics often depends not only on the future outlook of the potential Abeona Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Abeona Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.4 M | |
| Cash And Short Term Investments | 52.2 M |
Check out Abeona Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.38) | Return On Equity (1.27) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.